Current Anti-angiogenic Therapies and Their Limitations

dc.contributor.author	Mukherjee S.; Madamsetty V.S.
dc.date.accessioned	2025-05-23T11:23:53Z
dc.description.abstract	The process consist of angiogenesis presents the supply of blood to malignant cells promoting cancer development, invasion, and subsequent metastasis (Yoncheva and Momekov in Expert Opin Drug Deliv 8:1041–1056, 2011, [1]). The cancer cells live on high supply of blood and other nutrients. © 2022, The Author(s), under exclusive license to Springer Nature Switzerland AG.
dc.identifier.doi	https://doi.org/10.1007/978-3-031-11284-3_2
dc.identifier.uri	http://172.23.0.11:4000/handle/123456789/9495
dc.relation.ispartofseries	Synthesis Lectures on Biomedical Engineering
dc.title	Current Anti-angiogenic Therapies and Their Limitations

Collections